SCHEMBL2468705

SCHEMBL2468705

CCC(=O)C(C)(C)C(=O)C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CES2 O00748 8/20 0.39
FAAH O00519 13/20 0.38
CES1 P23141 11/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PLA2G6 O60733 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL901732 0.79 TDP1 (0.33)
SCHEMBL2545646 0.78 ALDH1A1 (0.41) CES2FAAHCES1
SCHEMBL458908 0.75
SCHEMBL4841349 0.75 FFAR3 (0.36)
SCHEMBL6011032 0.73 FFAR3 (0.35)
SCHEMBL27872049 0.73
SCHEMBL810063 0.73
SCHEMBL4854338 0.71
SCHEMBL4140338 0.70 TDP1 (0.42)
SCHEMBL29661116 0.70 CES2 (0.33) CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1642931-B1 EMULSION COMPOSITION OF MODIFIED POLYPROPYLENE TONEN SEKIYUKAGAKU KK (JP) 2011-10-05 EP disclosed
US-7785735-B2 Microporous composite membrane and its producing method and use TONEN CHEMICAL CORPORATION (JP) 2010-08-31 US disclosed
EP-1693408-B1 MICROPOROUS COMPOSITE FILM, PROCESS FOR PRODUCING THE SAME, AND USE TONEN SEKIYUKAGAKU KK (JP) 2010-04-14 EP disclosed
US-20070128512-A1 Microporous composite membrane and its producing method and use TORAY INDUSTRIES, INC. (JP) 2007-06-07 US disclosed
US-20070004847-A1 Emulsion composition of modified polypropylene TONEN CHEMICAL CORPORATION (JP) 2007-01-04 US disclosed
US-20060281859-A1 Method for producing modified polyolefin solution TONEN CHEMICAL CORPORATION (JP) 2006-12-14 US disclosed
EP-1693408-A1 MICROPOROUS COMPOSITE FILM, PROCESS FOR PRODUCING THE SAME, AND USE Tonen Chemical Corporation (JP) 2006-08-23 EP disclosed
EP-1645573-A1 PROCESS FOR PRODUCING MODIFIED POLYOLEFIN Tonen Chemical Corporation (JP) 2006-04-12 EP disclosed
EP-1642931-A1 EMULSION COMPOSITION OF MODIFIED POLYPROPYLENE Tonen Chemical Corporation (JP) 2006-04-05 EP disclosed
EP-1607415-A1 METHOD FOR PRODUCING MODIFIED POLYOLEFIN SOLUTION Tonen Chemical Corporation (JP) 2005-12-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004847-A1 Emulsion composition of modified polypropylene POLD1, DDHD2, POP1 CES2 2388/4885FAAH 607/4885CES1 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.